$72.81
2.19%
Nasdaq, Oct 15, 02:13 pm EDT. Market open.

Microchip Technology Target price 2026 - Analyst rating & recommendation

Microchip Technology Classifications & Recommendation

Buy
79%
Hold
21%

Microchip Technology Price Target

Target Price $108.63
Price $71.25
Potential 52.46%
Number of Estimates 28
28 Analysts have issued a price target Microchip Technology 2027 . The average Microchip Technology target price is $108.63. This is 52.46% higher than the current stock price. The highest price target is $141.75 98.95% , the lowest is $80.80 13.40% .
A rating was issued by 33 analysts: 26 Analysts recommend Microchip Technology to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Microchip Technology stock has an average upside potential 2027 of 52.46% . Most analysts recommend the Microchip Technology stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2031

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Revenue Billion $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

29 Analysts have issued a sales forecast Microchip Technology 2027 . The average Microchip Technology sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2026 $4.7b 7.08%
2027
2028
2029
2030
2031

15 Analysts have issued an Microchip Technology EBITDA forecast 2027. The average Microchip Technology EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 $961m 10.91%
2027
2028
2029
2030

EBITDA Margin

2026 20.39% 3.58%
2027
2028
2029

29 Microchip Technology Analysts have issued a net profit forecast 2027. The average Microchip Technology net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $119m 4,500.00%
2027
2028
2029
2030
2031

Net Margin

2026 2.52% 4,209.19%
2027
2028
2029
2030
2031

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

29 Analysts have issued a Microchip Technology forecast for earnings per share. The average Microchip Technology EPS is

. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $0.22 2,300.00%
2027
2028
2029
2030
2031

P/E ratio

Current 106.34 159.85%
2027
2028
2029
2030
2031

Based on analysts' sales estimates for 2027, the Microchip Technology stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.55 3.39%
2027
2028
2029
2030
2031

P/S ratio

Current 7.55 1.87%
2027
2028
2029
2030
2031

Current Microchip Technology Upgrades & Downgrades

Analyst Rating Action Date
BMO Capital
Outperform
➜
Outperform
Initiated Aug 21 2026
Cantor Fitzgerald
Overweight
➜
Overweight
Unchanged Aug 17 2026
UBS
Buy
➜
Buy
Unchanged Aug 07 2026
Citigroup
Buy
➜
Buy
Unchanged Aug 07 2026
Rosenblatt
Buy
➜
Buy
Unchanged Aug 07 2026
Truist Securities
Hold
➜
Hold
Unchanged Aug 07 2026
Cantor Fitzgerald
Overweight
➜
Overweight
Unchanged Aug 03 2026
Analyst Rating Date
Initiated
BMO Capital:
Outperform
➜
Outperform
Aug 21 2026
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
Aug 17 2026
Unchanged
UBS:
Buy
➜
Buy
Aug 07 2026
Unchanged
Citigroup:
Buy
➜
Buy
Aug 07 2026
Unchanged
Rosenblatt:
Buy
➜
Buy
Aug 07 2026
Unchanged
Truist Securities:
Hold
➜
Hold
Aug 07 2026
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
Aug 03 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today